Novo Nordisk has reached the end of its two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for breaches of its code of practice, after showing "significant and ...

The PMCPA is the independent body which administers the ABPI code, which covers the promotion of prescription medicines to UK health professionals and other relevant decision-makers, as well as ...

The Association of the British Pharmaceutical Industry (ABPI) reinstated Novo Nordisk’s membership in the group. 1 The company had previously been subjected to a two-year suspension of its membership, ...